Literature DB >> 16936284

Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives.

Sheng-Hsiang Lin1, Chih-Min Liu, Shu-Sen Chang, Hai-Gwo Hwu, Shi K Liu, Tzung J Hwang, Ming-Hsien Hsieh, Shi-Chin Guo, Wei J Chen.   

Abstract

Though a reduced flush response to niacin has been found in schizophrenic patients, whether it is a vulnerability indicator to schizophrenia remains little known. We aimed to examine the familial aggregation in niacin flush response among schizophrenic patients and their nonpsychotic relatives. In a sample of 153 schizophrenia probands, 217 parents, 70 siblings, and 94 normal subjects, 3 concentrations (0.001 M, 0.01 M, and 0.1 M) of niacin were applied to the forearm skin and the flush response was rated at 5, 10, and 15 minutes, respectively, with a 4-point scale. Both the heritability for continuous flush scores and the recurrence risk ratios for binary non-flush response in the nonpsychotic relatives of schizophrenic patients were estimated, and ordinal logistic regression analyses of relatives' niacin response on probands' were further conducted to adjust for potential confounders. The greatest heritabilities ranged from 47% (0.01 M at 10 minutes) to 54% (0.1 M at 5 minutes). The risk ratios of 0.01 M at 10 minutes (ranging from 2.60 for using score 1 or less to 5.06 for using score 0 as non-flush) and 5 minutes (1.66 for using score 0 as non-flush) were significantly greater than one. Multiple ordinal logistic regression analyses further revealed that the association between probands and relatives in niacin flush response remained after adjustment for potential confounders, including age, sex, allergy, tobacco smoking, and coffee drinking. These findings provide support for the potential of niacin flush response as a vulnerability indicator to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936284      PMCID: PMC2632299          DOI: 10.1093/schbul/sbl038

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  33 in total

1.  [Quantitative measurement of induced skin reddening using optical reflection spectroscopy--methodology and clinical application].

Authors:  S Smesny; S Riemann; S Riehemann; M E Bellemann; H Sauer
Journal:  Biomed Tech (Berl)       Date:  2001-10       Impact factor: 1.411

2.  Normal phospholipid-related signal transduction in autism.

Authors:  Basant K Puri; Iqbal Singh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-12       Impact factor: 5.067

3.  An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response.

Authors:  S D Turenne; M Seeman; B M Ross
Journal:  Schizophr Res       Date:  2001-07-01       Impact factor: 4.939

4.  Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics.

Authors:  M C Waldo
Journal:  Schizophr Res       Date:  1999-11-09       Impact factor: 4.939

5.  The niacin skin flush test in schizophrenia: a replication study.

Authors:  B K Puri; T Easton; I Das; L Kidane; A J Richardson
Journal:  Int J Clin Pract       Date:  2001 Jul-Aug       Impact factor: 2.503

6.  A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia.

Authors:  Basant K Puri; Steven R Hirsch; Terese Easton; Alexandra J Richardson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-01       Impact factor: 5.067

7.  Increased phospholipase A2 activity in schizophrenia with absent response to niacin.

Authors:  Hildeberto Tavares; Juliana Yacubian; Leda L Talib; Nádia R Barbosa; Wagner F Gattaz
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

8.  Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan.

Authors:  Ching-Jui Chang; Wei J Chen; Shi K Liu; Joseph J Cheng; Wen-Chen Ou Yang; Hung-Jung Chang; Hsien-Yuan Lane; Shi-Kwang Lin; Tien-Wei Yang; Hai-Gwo Hwu
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

9.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Authors:  J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich
Journal:  Arch Gen Psychiatry       Date:  1994-11

10.  Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.

Authors:  Stefan Smesny; Gregor Berger; Timm Rosburg; Sven Riemann; Stefan Riehemann; Patrick McGorry; Heinrich Sauer
Journal:  J Psychiatr Res       Date:  2003 May-Jun       Impact factor: 4.791

View more
  12 in total

Review 1.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

2.  A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia.

Authors:  Yin-Ju Lien; Sih-Syuan Huang; Chih-Min Liu; Hai-Gwo Hwu; Stephen V Faraone; Ming T Tsuang; Wei J Chen
Journal:  Schizophr Bull       Date:  2011-06-07       Impact factor: 9.306

3.  Niacin sensitivity and the arachidonic acid pathway in schizophrenia.

Authors:  Erik Messamore; William F Hoffman; Jeffrey K Yao
Journal:  Schizophr Res       Date:  2010-04-24       Impact factor: 4.939

4.  Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship.

Authors:  Ya-Hui Yu; Hui-Min Su; Sheng-Hsiang Lin; Po-Chang Hsiao; Yi-Ting Lin; Chih-Min Liu; Tzung-Jeng Hwang; Ming H Hsieh; Chen-Chung Liu; Yi-Ling Chien; Chian-Jue Kuo; Hai-Gwo Hwu; Wei J Chen
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-20

Review 5.  Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.

Authors:  Stella Aslibekyan; Robert J Straka; Marguerite R Irvin; Steven A Claas; Donna K Arnett
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-03

6.  Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Clara H Gautier; Gretchen L Haas; Ruth Condray; John W Kasckow; Benjamin L Kisslinger; John A Gurklis; Erik Messamore
Journal:  Schizophr Bull       Date:  2015-09-14       Impact factor: 9.306

7.  Improving risk assessment and familial aggregation of age at onset in schizophrenia using minor physical anomalies and craniofacial measures.

Authors:  I-Ning Tsai; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Shu-Ting Gan; Sheng-Hsiang Lin
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading.

Authors:  Shu-Sen Chang; Chih-Min Liu; Sheng-Hsiang Lin; Hai-Gwo Hwu; Tzung J Hwang; Shi K Liu; Ming H Hsieh; Shi-Chin Guo; Wei J Chen
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

9.  Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses.

Authors:  Motoko Maekawa; Noriko Takashima; Miho Matsumata; Shiro Ikegami; Masanori Kontani; Yoshinobu Hara; Hiroshi Kawashima; Yuji Owada; Yoshinobu Kiso; Takeo Yoshikawa; Kaoru Inokuchi; Noriko Osumi
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

10.  Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'.

Authors:  Brian M Ross; Martin Katzman
Journal:  BMC Res Notes       Date:  2008-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.